• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

What is causing this patient's severe pruritus?

作者信息

Probst Emily A, Smith Alyson L, Abad John D

机构信息

At the time this article was written, Emily A. Probst was a student in the PA program at Midwestern University in Downers Grove, Ill. She now practices in orthopedic surgery at the Medical College of Wisconsin in Milwaukee, Wisc. Alyson L. Smith is an associate professor in the PA program at Midwestern University in Downers Grove, Ill. John D. Abad is director of surgical oncology and gastrointestinal oncology for the Northwestern Medicine West Region, and a clinical assistant professor of surgery in the Northwestern University Feinberg School of Medicine in Warrenville, Ill. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2020 Jun;33(6):54-56. doi: 10.1097/01.JAA.0000662428.39636.70.

DOI:10.1097/01.JAA.0000662428.39636.70
PMID:32452965
Abstract
摘要

相似文献

1
What is causing this patient's severe pruritus?
JAAPA. 2020 Jun;33(6):54-56. doi: 10.1097/01.JAA.0000662428.39636.70.
2
CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.新辅助FOLFIRINOX化疗后对交界性和局部晚期胰腺腺癌的CT评估。
Eur Radiol. 2017 Jul;27(7):3104-3116. doi: 10.1007/s00330-016-4632-8. Epub 2016 Nov 28.
3
Management of diabetes and pancreatic cancer.糖尿病与胰腺癌的管理
Oncol Nurs Forum. 2012 Sep;39(5):440-3. doi: 10.1188/12.ONF.440-443.
4
Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer.原发性食管癌成功治疗三年后发生第二原发性胰腺癌。
JOP. 2014 Jan 10;15(1):46-8. doi: 10.6092/1590-8577/1892.
5
FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
Pancreas. 2012 Aug;41(6):973-4. doi: 10.1097/MPA.0b013e3182496e90.
6
First description of an uterine perforation potentially imputable to treatment with bevacizumab.首次描述了可能归因于贝伐单抗治疗的子宫穿孔。
Acta Oncol. 2012 Nov;51(8):1102-4. doi: 10.3109/0284186X.2012.689855. Epub 2012 Oct 1.
7
Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX.FOLFIRINOX方案治疗胰腺腺癌的病理完全缓解
BMJ Case Rep. 2018 Sep 1;2018:bcr-2018-225621. doi: 10.1136/bcr-2018-225621.
8
Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.FOLFOX辅助化疗后出现致命结局的机化性肺炎。
Arch Bronconeumol. 2015 Nov;51(11):610. doi: 10.1016/j.arbres.2015.05.010. Epub 2015 Jul 7.
9
A Pancreatic Predicament.
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):296-297. doi: 10.1016/j.ijrobp.2017.05.024.
10
Neoadjuvant therapy for localized pancreatic cancer: support is growing?局部胰腺癌的新辅助治疗:支持率在上升吗?
Ann Surg. 2015 Jan;261(1):18-20. doi: 10.1097/SLA.0000000000000996.